Výsledky vyhledávání - "Aideen Therese O'Neill"

The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective single‐centre series

Autor: Leon Menezes, Victoria Grandage, Andres Virchis, Kirit M. Ardeshna, Raakhee Shah, Kirsten Von Both, Stephen Daw, Jonathan Lambert, Ben Carpenter, Annabel McMillan, Aideen Therese O'Neill, William Townsend, Paul Humphries, Rachael Hough

Publikováno v: British Journal of Haematology. 192

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e99c4dacaafc8cd5e43028b3e60472d0
https://doi.org/10.1111/bjh.17274

Zobrazit plný text záznamu

Focal, Symptomatic Bone Marrow Lesions in Waldenström Macroglobulinaemia Characterised By Dense Infiltration with Lymphoplasmacytic Lymphoma: A Newly Defined Indication for Systemic Treatment

Autor: Aideen Therese O'Neill, Suzanne O Arulogun, Simon Wan, Irfan Kayani, Shirley D'Sa, Maaz Ali Abbasi, Sabine Pomplun

Publikováno v: Blood. 136:3-4

BACKGROUND Waldenström Macroglobulinaemia (WM) is an indolent, IgM-producing lymphoplasmacytic lymphoma (LPL) that infiltrates bone marrow (BM) and other tissues. Only symptomatic patients (with IgM-related complications, cytopenias, constitutional

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d2ad0b61f009dfdf227c83ad1a984e74
https://doi.org/10.1182/blood-2020-138716

Zobrazit plný text záznamu

Bendamustine Plus Rituximab for the Treatment of Waldenström Macroglobulinaemia: Patient Outcomes and Impact of Bendamustine Dosing

Publikováno v: Blood. 136:10-11

BACKGROUND Bendamustine and Rituximab (BR) therapy is recommended in international consensus guidelines for treatment of Waldenström Macroglobulinaemia (WM) in both frontline and relapsed settings. The optimal dose and schedule of Bendamustine is no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4b8cdbbb8c5b4c784e2728a3a722a8ea
https://doi.org/10.1182/blood-2020-140774

Zobrazit plný text záznamu

Systemic mastocytosis: variable manifestations can lead to a challenging diagnostic process

Autor: Andrew Wilson, Mallika Sekhar, Susanna Nallamilli, Jonathan Lambert, Aideen Therese O'Neill

Publikováno v: BMJ Case Rep

Systemic mastocytosis results from proliferation and activation of an abnormal mast cell clone. It is a heterogeneous disorder with clinical manifestations ranging from skin lesions alone to aggressive multi-organ infiltration and decreased survival.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f10f3b289fca4062b4456a85546e9ea
https://doi.org/10.1136/bcr-2019-229967

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání